Molecule intelOpportunity: LowerEssential

Cyclizine

9 brands · 7 companies · product forms

ATC: R06AE03

Opportunity snapshot

Launch attractiveness
24
Market saturation
18
Price room
0
Regulatory risk
0
9
brands
7
companies
Rs 112.61
median price
2
price points
1x
price spread
75
confidence %

Who competes here

Top companies by brand count · leader share 22%

Price room

Across observed sources and strengths
CheapestRs 112.61
MedianRs 112.61
Most expensiveRs 112.61
Spread1×
Sources: DRAP-official, Servaid

Only 2 trusted price points; variation not scored (low data).

Brands & products on the market

Sample of 2 live products for Cyclizine — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(0) + 20% low-competition(82) + 15% supply-disruption(0), damped by confidence(75). Higher = more attractive, less crowded opportunity.

Market saturation

7 canonical companies and 9 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

Only 2 trusted price points; variation not scored (low data).

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: sparse price data.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.